概括
尼古丁酸有效地减少了严重霍乱患者的肠道液体损失. 与对照组相比,2g剂量在减少流体流失和便量方面显示出显著的益处.
科学领域:
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的霍乱会导致显著的肠道分泌物和流体流失.
- 现有的治疗方法旨在控制液体和电解质平衡.
研究的目的:
- 评估尼古丁酸在严重霍乱中减少肠道分泌物的有效性.
- 为了确定治疗效果的最佳剂量.
主要方法:
- 一项随机对照试验,涉及62名患有严重霍乱的成年患者.
- 向29名患者口服1g或2g尼古丁酸,分剂量.
- 与33名对照患者的流体损失和便量进行比较.
主要成果:
- 尼古丁酸2g剂量在治疗后的前16小时显著减少了流体损失 (p<0.01和p<0.05).
- 药物特异性便减少在前16小时内从31%到47%不等.
- 2g剂量明显比1g剂量更有效,在治疗开始8-16小时后观察到峰值抑制.
- 尼古丁酸的耐受性很好,在一名患者报告过渡性冲.
结论:
- 尼古丁酸,特别是2g剂量,是减少严重霍乱的肠道分泌物的有希望的药物.
- 进一步的研究可能会探索它作为霍乱管理中的辅助疗法的作用.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
03:25Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
